1. Home
  2. EYPT vs GSL Comparison

EYPT vs GSL Comparison

Compare EYPT & GSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$11.92

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

GSL

Global Ship Lease Inc New

HOLD

Current Price

$43.34

Market Cap

1.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYPT
GSL
Founded
1987
2007
Country
United States
Greece
Employees
N/A
7
Industry
Biotechnology: Laboratory Analytical Instruments
Marine Transportation
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
EYPT
GSL
Price
$11.92
$43.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$31.80
$44.00
AVG Volume (30 Days)
1.5M
256.6K
Earning Date
05-06-2026
05-18-2026
Dividend Yield
N/A
6.34%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,539,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3,115.57
N/A
P/E Ratio
N/A
$3.49
Revenue Growth
N/A
N/A
52 Week Low
$9.41
$27.28
52 Week High
$19.11
$43.89

Technical Indicators

Market Signals
Indicator
EYPT
GSL
Relative Strength Index (RSI) 36.19 67.07
Support Level $9.65 $37.00
Resistance Level $13.32 N/A
Average True Range (ATR) 0.81 0.89
MACD -0.23 0.27
Stochastic Oscillator 3.24 88.25

Price Performance

Historical Comparison
EYPT
GSL

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

About GSL Global Ship Lease Inc New

Global Ship Lease Inc is a containership owner, leasing ships to container shipping companies under industry-standard, fixed-rate time charters. Its fleet comprises mid-size Post-Panamax, Cypress, and smaller containerships, which tend to serve the faster-growing non-Mainlane and intra-regional trades, collectively representing the majority of the containerized trade volume globally. The company generates revenue from chartering its vessels to liner companies.

Share on Social Networks: